NAC Attack, a phase-3, multicenter, randomized, placebo-controlled trial with retinitis pigmentosa: OCT Reading Center
Clinical Trial Grant
Administered By
Ophthalmology
Awarded By
National Institutes of Health
Start Date
March 17, 2022
End Date
February 28, 2027
Administered By
Ophthalmology
Awarded By
National Institutes of Health
Start Date
March 17, 2022
End Date
February 28, 2027